Research Article
Preprocedural Hypertension Is Not a Risk Factor for Postoperative Bleeding following Image-Guided Core Needle Breast Biopsy
Table 1
Demographic and clinical characteristic of subjects by preprocedural hypertension.
| | | All patients (n = 332) | Preprocedural hypertension (n = 104) | Normotensive (n = 228) | P value ^ |
| | Age (in years) | 59 (13) | 63 (13) | 57 (12) | <0.001^ | | History of smoking (current or past) | 37 (11%) | 4 (4%) | 33 (15%) | 0.004 ^ | | History of hypertension | 131 (39%) | 55 (53%) | 76 (33%) | <0.001^ | | History of hematological disorders affecting hemostasis | 6 (2%) | 1 (1%) | 5 (2%) | 0.435 | | Antithrombotic/antiplatelet medications | 17 (5%) | 8 (8%) | 9 (4%) | 0.151 | | Type of biopsy | | | | | | Ultrasound-guided | 251 (77%) | 79 (77%) | 172 (77%) | 0.895 | | Stereotactic | 81 (24%) | 24 (23%) | 57 (25%) | 0.690 | | Tethered vacuum-assisted device | 76 (23%) | 25 (24%) | 51 (23%) | 0.768 | | Needle gauge ≥12 | 180 (68%) | 59 (71%) | 121 (67%) | 0.531 | | Bleeding after biopsy (in minutes) | 13 (8) | 13 (7) | 13 (8) | 0.856 | | Prolonged postbiopsy bleeding (>15 minutes) | 32 (12%) | 11 (13%) | 21 (12%) | 0.765 |
|
|
Mean (standard deviation). Frequency (percentage). ^Statistically significant value (<0.05). |
